Tuberculosis remains one of medicine's most urgent unsolved problems — not because science lacks tools, but because implementation gaps, funding volatility, and drug resistance are conspiring to keep the disease entrenched. A comprehensive 33-year accounting now reveals precisely how far the world is from its own 2035 elimination targets, with the MDR-TB picture especially alarming at a moment when global health financing is under severe strain.
Drawing on the Global Burden of Disease Study 2023 — the most expansive disease modeling exercise in existence — researchers systematically quantified TB mortality, incidence, prevalence, and disability-adjusted life-years (DALYs) across 204 countries and territories from 1990 through 2023. The analysis stratified outcomes by HIV co-infection status and drug-resistance profile, using DisMod-MR 2.1 for morbidity and a Cause of Death Ensemble model fed by vital registration, surveillance, verbal autopsy, and minimally invasive tissue sampling data. A comparative risk framework additionally attributed burden fractions to modifiable exposures — alcohol use, smoking, and elevated fasting plasma glucose — offering a rare causal decomposition of a predominantly infectious disease burden. Progress toward the WHO End TB Strategy's dual 2035 targets (95% mortality reduction, 90% incidence reduction from 2015 baselines) was formally evaluated.
The GBD framework's strength is its ability to synthesize heterogeneous national data systems into comparable estimates — critical for a disease whose surveillance quality varies enormously by income setting. However, modeled estimates carry uncertainty intervals that widen substantially in high-burden, low-data-quality regions, precisely where the numbers matter most. The HIV–TB intersection remains a particular analytical challenge, since cause-of-death attribution between the two conditions is notoriously inconsistent across registries. What makes this analysis potentially paradigm-shifting is its timing: documenting baseline burden just as donor funding contractions threaten to reverse two decades of hard-won gains creates an irreplaceable policy anchor. For health-conscious adults, the metabolic risk factor findings are notable — high fasting glucose as a TB burden contributor reinforces that metabolic health has infectious disease consequences extending well beyond cardiovascular risk.